Ilang to work with its Chinese arm on Supect

Published: 2013-07-02 06:57:00
Updated: 2013-07-02 06:57:00
Ilyang Pharmaceutical announced last Saturday that it signed a memorandum of understanding with its Chinese arm Yangzhou Ilyang Pharmaceutical in China for the production and sales of Supect (rodotinib).

Yangzhou Ilyang is a joint venture where Ilyang has a 52 percent stake, while Gaoyou City ...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.